Armistice Capital, LLC 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Armistice Capital, LLC disclosed 323 US equity positions worth $3.6bn in its Q2 2026 13F filing. The largest position was MDGL at 4.3% of the reported book, followed by SUPN and CYTK. Against the Q1 2026 filing, it opened 1 new position, added to 30 and reduced 17 among the top 50 holdings.
What did Armistice Capital, LLC own in Q2 2026? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 4.3% | $154.6m | 288,000 | 9% | added |
| 2 | SUPN SUPERNUS PHARMACEUTICALS | Healthcare | 3.4% | $123.1m | 2,646,201 | 40% | added |
| 3 | CYTK CYTOKINETICS INC | Healthcare | 2.8% | $102.3m | 1,201,342 | 57% | added |
| 4 | INCY INCYTE CORP | Healthcare | 2.8% | $102.0m | 900,005 | 37% | added |
| 5 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.5% | $90.3m | 535,838 | -26% | reduced |
| 6 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 2.5% | $89.3m | 1,572,539 | -68% | reduced |
| 7 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 2.5% | $89.1m | 2,400,000 | -12% | reduced |
| 8 | PTCT PTC THERAPEUTICS INC | Healthcare | 2.4% | $87.4m | 1,071,395 | -48% | reduced |
| 9 | UNH UNITEDHEALTH GROUP INC | Healthcare | 2.1% | $76.1m | 183,000 | 24% | added |
| 10 | FRPT FRESHPET INC | Consumer Defensive | 2.1% | $74.5m | 1,260,702 | 15% | added |
| 11 | DYN DYNE THERAPEUTICS INC | Healthcare | 1.9% | $68.6m | 3,087,226 | -3% | reduced |
| 12 | AMZN AMAZON COM INC | Consumer Cyclical | 1.9% | $67.8m | 284,562 | 9% | added |
| 13 | IMVT IMMUNOVANT INC | Healthcare | 1.9% | $66.9m | 1,736,000 | -51% | reduced |
| 14 | RIGL RIGEL PHARMACEUTICALS INC | 1.8% | $65.4m | 1,672,000 | 31% | added | |
| 15 | TMO THERMO FISHER SCIENTIFIC INC | Healthcare | 1.7% | $61.4m | 122,480 | 34% | added |
| 16 | IRWD IRONWOOD PHARMACEUTICALS INC | Healthcare | 1.6% | $58.7m | 13,932,000 | -7% | reduced |
| 17 | HRMY HARMONY BIOSCIENCES HLDGS IN | Healthcare | 1.6% | $56.9m | 1,564,000 | -4% | reduced |
| 18 | REGN REGENERON PHARMACEUTICALS | Healthcare | 1.5% | $56.0m | 89,809 | 149% | added |
| 19 | NKTR NEKTAR THERAPEUTICS | Healthcare | 1.4% | $50.5m | 724,000 | 25% | added |
| 20 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.3% | $46.8m | 1,736,000 | 48% | added |
| 21 | SNY SANOFI SA | Healthcare | 1.3% | $45.4m | 1,064,000 | 255% | added |
| 22 | IMCR IMMUNOCORE HLDGS PLC | Healthcare | 1.3% | $45.3m | 1,428,000 | 20% | added |
| 23 | GOOGL ALPHABET INC | Communication Services | 1.3% | $45.2m | 126,494 | 7% | added |
| 24 | SLDB SOLID BIOSCIENCES INC | Healthcare | 1.2% | $42.7m | 4,278,000 | 34% | added |
| 25 | MDB MONGODB INC | Technology | 1.2% | $42.0m | 125,172 | 17% | added |
| 26 | KURA KURA ONCOLOGY INC | Healthcare | 1.1% | $40.3m | 3,678,000 | -2% | reduced |
| 27 | XRAY DENTSPLY SIRONA INC | Healthcare | 1.1% | $39.0m | 3,672,000 | 22% | added |
| 28 | UBER UBER TECHNOLOGIES INC | Technology | 1.0% | $35.9m | 497,908 | -4% | reduced |
| 29 | AXGN AXOGEN INC | Healthcare | 1.0% | $35.8m | 775,000 | -17% | reduced |
| 30 | IRON DISC MEDICINE INC | Healthcare | 0.9% | $33.6m | 460,000 | -14% | reduced |
| 31 | GTLB GITLAB INC | Technology | 0.9% | $32.8m | 1,074,141 | 4% | added |
| 32 | FIVN FIVE9 INC | Technology | 0.9% | $32.7m | 1,536,000 | -4% | reduced |
| 33 | HUBS HUBSPOT INC | Technology | 0.9% | $32.5m | 178,047 | 38% | added |
| 34 | ALGN ALIGN TECHNOLOGY INC | Healthcare | 0.8% | $30.4m | 180,286 | 14% | added |
| 35 | MSFT MICROSOFT CORP | Technology | 0.8% | $30.1m | 80,581 | 65% | added |
| 36 | OFIX ORTHOFIX MED INC | Healthcare | 0.8% | $29.8m | 3,264,000 | 21% | added |
| 37 | HUM HUMANA INC | Healthcare | 0.8% | $28.8m | 72,527 | -49% | reduced |
| 38 | ANGO ANGIODYNAMICS INC | Healthcare | 0.8% | $28.6m | 2,198,000 | 18% | added |
| 39 | WAT WATERS CORP | Healthcare | 0.8% | $28.1m | 75,004 | – | new |
| 40 | VSTM VERASTEM INC | Healthcare | 0.7% | $26.8m | 7,024,000 | 53% | added |
| 41 | FDMT 4D MOLECULAR THERAPEUTICS IN | Healthcare | 0.7% | $26.6m | 2,000,000 | 0% | held |
| 42 | NTLA INTELLIA THERAPEUTICS INC | Healthcare | 0.7% | $25.4m | 1,500,000 | 346% | added |
| 43 | WYNN WYNN RESORTS LTD | Consumer Cyclical | 0.7% | $25.3m | 261,065 | 50% | added |
| 44 | TMCI TREACE MED CONCEPTS INC | Healthcare | 0.7% | $25.3m | 6,364,000 | 0% | held |
| 45 | AUTL AUTOLUS THERAPEUTICS LTD | Healthcare | 0.7% | $24.0m | 15,000,000 | -5% | reduced |
| 46 | ARVN ARVINAS INC | Healthcare | 0.6% | $23.2m | 2,796,000 | 41% | added |
| 47 | MGNX MACROGENICS INC | Healthcare | 0.6% | $23.1m | 5,006,752 | -17% | reduced |
| 48 | ANRO ALTO NEUROSCIENCE INC | Healthcare | 0.6% | $22.8m | 864,000 | -5% | reduced |
| 49 | TOST TOAST INC | Technology | 0.6% | $22.6m | 810,830 | 40% | added |
| 50 | PATH UIPATH INC | Technology | 0.6% | $21.7m | 2,000,000 | 56% | added |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.